Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- Treague Ltd
- Target Recruit Count
- 46
- Registration Number
- NCT00931697
- Locations
- 🇬🇧
LCG Bioscience, Cambridge, Cambridgeshire, United Kingdom
News
No news found